4//SEC Filing
MOLKENTIN MICHAEL 4
Accession 0001179110-13-006787
CIK 0000919722other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 7:26 PM ET
Size
6.9 KB
Accession
0001179110-13-006787
Insider Transaction Report
Form 4
MOLKENTIN MICHAEL
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2013-04-10$1.65/sh+7,500$12,375→ 26,495 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2013-04-10−7,500→ 67,500 totalExercise: $1.65Exp: 2019-03-12→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The Reporting Person exercised 7,500 of the 80,000 share option granted March 12, 2009. The option vested at the rate of 1/48th of the shares on April 12, 2009 and at the end of each full month thereafter.
- [F2]Includes 3,000 shares acquired under the Issuer's 2008 Employee Stock Purchase Plan.
Documents
Issuer
Astex Pharmaceuticals, Inc
CIK 0000919722
Entity typeother
Related Parties
1- filerCIK 0001268957
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 7:26 PM ET
- Size
- 6.9 KB